date:Jul 06, 2012
cations.
Under the agreement, Ball and Chrysantis will also continue to develop new and improved patent-protected marigold hybrids that offer high levels of dietary zeaxanthin.
A plant-based, dietary source of zeaxanthin from Chrysantis is a great strategic fit for Kemin,said Jeff Flora, president of the human nutrition and health division of Kemin.
Adding this new technology to our portfolio reinforces our continued commitment to provide quality, science-based ingredients with documented ben